Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity”

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Heart & lung 2023-03, Vol.58, p.256-257
1. Verfasser:	Dhakal, Sandesh
Format:	Artikel
Sprache:	eng
Schlagworte:	COVID-19 Hospitals Humans Letter to the Editor Patient Acuity Platelet Aggregation Inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	257
container_issue
container_start_page	256
container_title	Heart & lung
container_volume	58
creator	Dhakal, Sandesh
description
doi_str_mv	10.1016/j.hrtlng.2022.09.004
format	Article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9472803</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0147956322002114</els_id><sourcerecordid>2718636284</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-c768822cb9fd00d07c3eb23f82d6e19a0210a2dd8c92ac84da7eea3ab87b3b823</originalsourceid><addsrcrecordid>eNp9kc9uEzEQxq0K1Ia2b1ChPXLZxR5vbe8FCaUFKlUqB9qr5bUnjaPddbCdSL31QeDl-iQ4SilwYS6Wxt988-dHyBmjDaNMvF81y5iH6b4BCtDQrqG0PSAzdg6y5qDUKzKjrJV1dy74EXmT0oqW4EIekiMumOBA5YzczcM44pSrMFVPjz--RqyXIa19NkNlpuzXg8k4YK5GdN6a7Ituk3Ann9_cXV3UrKucT2hKLuEWo88PT48_T8jrhRkSnj6_x-T20-W3-Zf6-ubz1fzjdW1bBrm2UigFYPtu4Sh1VFqOPfCFAieQdYYCowacU7YDY1XrjEQ03PRK9rxXwI_Jh73vetOXCW3ZJJpBr6MfTXzQwXj978_kl_o-bHXXSlCUF4N3zwYxfN9gynr0yeIwmAnDJmmQTAkuQLVF2u6lNoaUIi5e2jCqd0j0Su-R6B0STTtdkJSyt3-P-FL0m8GfHbAcausx6mQ9TrYcPKLN2gX__w6_AHxQop8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2718636284</pqid></control><display><type>article</type><title>Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity”</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Dhakal, Sandesh</creator><creatorcontrib>Dhakal, Sandesh</creatorcontrib><identifier>ISSN: 0147-9563</identifier><identifier>ISSN: 1527-3288</identifier><identifier>EISSN: 1527-3288</identifier><identifier>DOI: 10.1016/j.hrtlng.2022.09.004</identifier><identifier>PMID: 36163207</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>COVID-19 ; Hospitals ; Humans ; Letter to the Editor ; Patient Acuity ; Platelet Aggregation Inhibitors</subject><ispartof>Heart & lung, 2023-03, Vol.58, p.256-257</ispartof><rights>2022</rights><rights>2022 Published by Elsevier Inc. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c412t-c768822cb9fd00d07c3eb23f82d6e19a0210a2dd8c92ac84da7eea3ab87b3b823</cites><orcidid>0000-0002-5798-7972</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.hrtlng.2022.09.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36163207$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dhakal, Sandesh</creatorcontrib><title>Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity”</title><title>Heart & lung</title><addtitle>Heart Lung</addtitle><subject>COVID-19</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Letter to the Editor</subject><subject>Patient Acuity</subject><subject>Platelet Aggregation Inhibitors</subject><issn>0147-9563</issn><issn>1527-3288</issn><issn>1527-3288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc9uEzEQxq0K1Ia2b1ChPXLZxR5vbe8FCaUFKlUqB9qr5bUnjaPddbCdSL31QeDl-iQ4SilwYS6Wxt988-dHyBmjDaNMvF81y5iH6b4BCtDQrqG0PSAzdg6y5qDUKzKjrJV1dy74EXmT0oqW4EIekiMumOBA5YzczcM44pSrMFVPjz--RqyXIa19NkNlpuzXg8k4YK5GdN6a7Ituk3Ann9_cXV3UrKucT2hKLuEWo88PT48_T8jrhRkSnj6_x-T20-W3-Zf6-ubz1fzjdW1bBrm2UigFYPtu4Sh1VFqOPfCFAieQdYYCowacU7YDY1XrjEQ03PRK9rxXwI_Jh73vetOXCW3ZJJpBr6MfTXzQwXj978_kl_o-bHXXSlCUF4N3zwYxfN9gynr0yeIwmAnDJmmQTAkuQLVF2u6lNoaUIi5e2jCqd0j0Su-R6B0STTtdkJSyt3-P-FL0m8GfHbAcausx6mQ9TrYcPKLN2gX__w6_AHxQop8</recordid><startdate>20230301</startdate><enddate>20230301</enddate><creator>Dhakal, Sandesh</creator><general>Elsevier Inc</general><general>Published by Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5798-7972</orcidid></search><sort><creationdate>20230301</creationdate><title>Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity”</title><author>Dhakal, Sandesh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-c768822cb9fd00d07c3eb23f82d6e19a0210a2dd8c92ac84da7eea3ab87b3b823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>COVID-19</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Letter to the Editor</topic><topic>Patient Acuity</topic><topic>Platelet Aggregation Inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dhakal, Sandesh</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Heart & lung</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dhakal, Sandesh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity”</atitle><jtitle>Heart & lung</jtitle><addtitle>Heart Lung</addtitle><date>2023-03-01</date><risdate>2023</risdate><volume>58</volume><spage>256</spage><epage>257</epage><pages>256-257</pages><issn>0147-9563</issn><issn>1527-3288</issn><eissn>1527-3288</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36163207</pmid><doi>10.1016/j.hrtlng.2022.09.004</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-5798-7972</orcidid><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0147-9563
ispartof	Heart & lung, 2023-03, Vol.58, p.256-257
issn	0147-9563 1527-3288 1527-3288
language	eng
recordid	cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9472803
source	MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects	COVID-19 Hospitals Humans Letter to the Editor Patient Acuity Platelet Aggregation Inhibitors
title	Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity”
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T19%3A00%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comment%20on%20%E2%80%9CPre-hospital%20antiplatelet%20medication%20use%20on%20COVID-19%20disease%20severity%E2%80%9D&rft.jtitle=Heart%20&%20lung&rft.au=Dhakal,%20Sandesh&rft.date=2023-03-01&rft.volume=58&rft.spage=256&rft.epage=257&rft.pages=256-257&rft.issn=0147-9563&rft.eissn=1527-3288&rft_id=info:doi/10.1016/j.hrtlng.2022.09.004&rft_dat=%3Cproquest_pubme%3E2718636284%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2718636284&rft_id=info:pmid/36163207&rft_els_id=S0147956322002114&rfr_iscdi=true